Rhabdomyolysis after taking Atorvastatin with Gemfibrozil

P. Barton Duell; William E. Connor; D. Roger Illingworth

doi:10.1016/S0002-9149(97)00907-7

Rhabdomyolysis after taking Atorvastatin with Gemfibrozil

P. Barton Duell, William E. Connor, D. Roger Illingworth

Knight Cardiovascular Institute

Research output: Contribution to journal › Article › peer-review

120 Scopus citations

Abstract

The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

Original language	English (US)
Pages (from-to)	368-369
Number of pages	2
Journal	American Journal of Cardiology
Volume	81
Issue number	3
DOIs	https://doi.org/10.1016/S0002-9149(97)00907-7
State	Published - Feb 1 1998

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0002-9149(97)00907-7

Cite this

@article{d3103f7b085b4ce8a6fba182015dcb61,

title = "Rhabdomyolysis after taking Atorvastatin with Gemfibrozil",

abstract = "The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.",

author = "Duell, {P. Barton} and Connor, {William E.} and Illingworth, {D. Roger}",

note = "Funding Information: This study was supported by funds from the Oregon Health Sciences Foundation, Portland, Oregon. ",

year = "1998",

month = feb,

day = "1",

doi = "10.1016/S0002-9149(97)00907-7",

language = "English (US)",

volume = "81",

pages = "368--369",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Rhabdomyolysis after taking Atorvastatin with Gemfibrozil

AU - Duell, P. Barton

AU - Connor, William E.

AU - Illingworth, D. Roger

N1 - Funding Information: This study was supported by funds from the Oregon Health Sciences Foundation, Portland, Oregon.

PY - 1998/2/1

Y1 - 1998/2/1

N2 - The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

AB - The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

UR - http://www.scopus.com/inward/record.url?scp=0032005257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032005257&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(97)00907-7

DO - 10.1016/S0002-9149(97)00907-7

M3 - Article

C2 - 9468088

AN - SCOPUS:0032005257

SN - 0002-9149

VL - 81

SP - 368

EP - 369

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 3

ER -

Rhabdomyolysis after taking Atorvastatin with Gemfibrozil

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this